SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-24-011106
Filing Date
2024-04-04
Accepted
2024-04-04 17:49:45
Documents
2
Period of Report
2024-04-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 6893
2 EXHIBIT 24 - POWER OF ATTORNEY stengone_poa.htm EX-24 8583
  Complete submission text file 0001437749-24-011106.txt   17021
Mailing Address 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 (858) 333-5280
Contineum Therapeutics, Inc. (Issuer) CIK: 0001855175 (see all company filings)

IRS No.: 271467257 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address
Stengone Carmine N. (Reporting) CIK: 0001861519 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42001 | Film No.: 24824217